Evidence map›Paper›PMID 41957088›Full record

ArticleScientific reports2026

Boronic acid affinity media conjugating with PEG enable precise pH-responsive HPLC separation of glycoproteins depending on differences of sugar chains.

Keisuke Koda, Sayaka Konishi-Yamada, Takuya Kubo

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Keisuke KodaDepartment of Material Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan.
Sayaka Konishi-YamadaGraduate School of Life and Environmental Science, Kyoto Prefectural University, 1-5 Shimogamo Hangi-cho, Sakyo-ku, Kyoto, 606-8522, Japan.
Takuya KuboDepartment of Material Chemistry, Graduate School of Engineering, Kyoto University, Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan. tkubo@kpu.ac.jp.

Funding

Environmental Restoration and Conservation Agency JPMEERF20235003Japan Science and Technology Corporation JPMJCR2332
6 · The paper itself

Abstract

Boronic acids (BAs) reversibly bind to diol structures in a pH-dependent manner and have attracted attention as a method for separating glycoproteins based on their sugar chains. However, commonly used phenylboronic acid reacts only under basic conditions, which can cause protein denaturation and aggregation. To address this issue, we focused on BPA, BBX, PBA-CF3, and PBA-F, which are expected to have lower pKa values due to their electron-withdrawing groups. In this study, we designed and synthesized a novel stationary phase by immobilizing these BA derivatives onto silica particles for HPLC separation of glycoproteins. First, polyethylene glycol (PEG) was introduced as a spacer. Its high hydrophilicity and excluded volume effect suppressed non-specific protein adsorption. At the same time, glycoproteins such as horseradish peroxidase and immunoglobulin were retained even under neutral pH conditions, likely due to complex formation with BA derivatives based on differences in sugar chains. Next, polyethylenimine (PEI) was introduced to increase the immobilization amount of BA derivatives. As a result, the binding affinity toward glycoproteins increased, and a wider range of glycoproteins were strongly retained. Finally, HPLC with a pH gradient was performed, and the elution order of glycoproteins changed depending on the type of BA derivative. This indicates that glycoprotein separation can be controlled by both the BA derivative used and the mobile phase pH.

Indexed as

Boronic acidsComplexationGlycoproteinsHPLCImmobilization

Identifiers

PMID41957088
PMCPMC13201654

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.